Featured Research

from universities, journals, and other organizations

Jefferson Researchers Show Melatonin’s Potential Benefits In Preventing Parkinson's Damage

Date:
October 25, 1999
Source:
Jefferson Medical College
Summary:
Melatonin could be a key to someday understanding how to treat Parkinson’s disease. Scientists at Jefferson Medical College have shown in the laboratory and in test animals that melatonin is effective in preventing a particular type of brain cell damage similar to that found in Parkinson’s.

Melatonin could be a key to someday understanding how to treat Parkinson’s disease. Scientists at Jefferson Medical College have shown in the laboratory and in test animals that melatonin is effective in preventing a particular type of brain cell damage similar to that found in Parkinson’s.

Many researchers believe that the loss of dopamine nerve cells seen in Parkinson’s disease patients’ brains results from oxidative stress to the cells. Various cellular insults produce oxygen free-radicals, resulting in cell death. The brain’s dopamine neurons are particularly vulnerable.

Melatonin, a hormone produced by the brain and which is marketed as an anti-aging agent commercially, is the body’s most potent antioxidant. Two years ago, Lorraine Iacovitti, Ph.D., professor of neurology at Thomas Jefferson University in Philadelphia, and her co-workers showed in the laboratory that melatonin was effective in blocking the oxidative ravages of Parkinson’s-damaged dopamine-producing cells.

Dr. Iacovitti and her team tested the theory in rats by giving the animals a toxin, 6-hydroxydopamine, which specifically damages dopamine neurons, producing a Parkinsonian-like syndrome. They found that by injecting melatonin into the rats either 10 minutes prior to the 6-hydroxy infusion or 30 minutes after, they could block the Parkinsonian effects. They were able to prevent about half of the damage, or "rescue the cells," if melatonin was given two hours later.

Dr. Iacovitti presents her team’s findings October 24 at the annual meeting of the Society for Neuroscience in Miami Beach.

"If you get enough antioxidants to the dopamine nerve cells, you might be able to prevent the kinds of oxidative stress and cell death you see in Parkinson’s," she says.

Dr. Iacovitti notes that melatonin "has the correct action to be developed pharmaceutically," but cautions that the dosages given to the test animals were extremely high. "Whether it could be developed into a drug is another question," she says. "It’s difficult to know at what levels to keep antioxidants in the body." A drug company might be able to isolate an active part of melatonin that could be a more effective antioxidant at lower doses.

She continues to study other examples of toxin-induced Parkinsonism, some of which cause damage by other means.

She explains that in oxidative stress, cells don’t automatically die. Rather, they pass through a cascade of cellular events leading to cell death. She and her team used melatonin to stop the cascade at its beginning. They would like to explore other checkpoints in the death cascade to gauge the compound’s effectiveness.


Story Source:

The above story is based on materials provided by Jefferson Medical College. Note: Materials may be edited for content and length.


Cite This Page:

Jefferson Medical College. "Jefferson Researchers Show Melatonin’s Potential Benefits In Preventing Parkinson's Damage." ScienceDaily. ScienceDaily, 25 October 1999. <www.sciencedaily.com/releases/1999/10/991025075751.htm>.
Jefferson Medical College. (1999, October 25). Jefferson Researchers Show Melatonin’s Potential Benefits In Preventing Parkinson's Damage. ScienceDaily. Retrieved October 21, 2014 from www.sciencedaily.com/releases/1999/10/991025075751.htm
Jefferson Medical College. "Jefferson Researchers Show Melatonin’s Potential Benefits In Preventing Parkinson's Damage." ScienceDaily. www.sciencedaily.com/releases/1999/10/991025075751.htm (accessed October 21, 2014).

Share This



More Mind & Brain News

Tuesday, October 21, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

First-Of-Its-Kind Treatment Gives Man Ability To Walk Again

First-Of-Its-Kind Treatment Gives Man Ability To Walk Again

Newsy (Oct. 21, 2014) A medical team has for the first time given a man the ability to walk again after transplanting cells from his brain onto his severed spinal cord. Video provided by Newsy
Powered by NewsLook.com
Your Birth Season Might Determine Your Temperament

Your Birth Season Might Determine Your Temperament

Newsy (Oct. 20, 2014) A new study says the season you're born in can determine your temperament — and one season has a surprising outcome. Video provided by Newsy
Powered by NewsLook.com
Movies Might Desensitize Violence For Parents, Not Just Kids

Movies Might Desensitize Violence For Parents, Not Just Kids

Newsy (Oct. 20, 2014) A study suggests that parents become desensitized to violent movies as well as children, which leads them to allow their kids to view violent films. Video provided by Newsy
Powered by NewsLook.com
Court Ruling Means Kids' Online Activity Could Be On Parents

Court Ruling Means Kids' Online Activity Could Be On Parents

Newsy (Oct. 17, 2014) In a ruling attorneys for both sides agreed was a first of its kind, a Georgia appeals court said parents can be held liable for what kids put online. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins